JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL.

MLA

Haselager, Marco V., et al. “JAK-STAT Signalling Shapes the NF-ΚB Response in CLL towards Venetoclax Sensitivity or Resistance via Bcl-XL.” Molecular Oncology, vol. 17, no. 6, June 2023, pp. 1112–28. EBSCOhost, https://doi.org/10.1002/1878-0261.13364.

APA

Haselager, M. V., Thijssen, R., Bax, D., Both, D., De Boer, F., Mackay, S., Dubois, J., Mellink, C., Kater, A. P., & Eldering, E. (2023). JAK-STAT signalling shapes the NF-κB response in CLL towards venetoclax sensitivity or resistance via Bcl-XL. Molecular Oncology, 17(6), 1112–1128. https://doi.org/10.1002/1878-0261.13364

Chicago

Haselager, Marco V, Rachel Thijssen, Danique Bax, Demi Both, Francien De Boer, Simon Mackay, Julie Dubois, Clemens Mellink, Arnon P Kater, and Eric Eldering. 2023. “JAK-STAT Signalling Shapes the NF-ΚB Response in CLL towards Venetoclax Sensitivity or Resistance via Bcl-XL.” Molecular Oncology 17 (6): 1112–28. doi:10.1002/1878-0261.13364.